Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bedford Park
Clinical trial register · Australia

Clinical Trials in Bedford Park, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hoffmann-La Roche7 Takeda6 Daiichi Sankyo6 Janssen Research & Development, LLC5 Gilead Sciences4
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Bedford Park

156 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Darlinghurst, Westmead, Brisbane, Bedford Park, Box Hill, Melbourne, Joondalup
2027-11-23
Not yet open
Olivia Newton-John Cancer Research Institute
Phase 2
40
Douglas, Woolloongabba, Bedford Park, Heidelberg, Murdoch
2026-12
Recruiting
Takeda
Phase 3
324
Bedford Park, Coffs Harbour, Cudgen, Kogarah
2026-09-10
Recruiting
Gilead Sciences
Phase 2
120
Camperdown, St Leonards, Herston, Bedford Park, Nedlands
2026-08-07
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
DrugsEtoposide·Atezolizumab·Carboplatin
SystImmune Inc.
Phase 3
550
Garran, Southport, Bedford Park
2026-08-04
Recruiting
Boehringer Ingelheim
Phase 3
390
St Leonards, Bedford Park, Melbourne, Murdoch
2026-07-10
Recruiting
A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors
NCT07524140Advanced Solid Tumor Cancer, Metastatic Solid Tumor
Eilean Therapeutics
Phase 1
60
Kogarah, Bedford Park
2026-06-25
Recruiting
Takeda
Phase 3
300
Coffs Harbour, Sydney, Waratah, Adelaide, Bedford Park, Clayton, Fitzroy, Heidelberg
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Canberra, Liverpool, Chelmer, Chermside, Ipswich, Milton, Adelaide, Bedford Park
2026-05-11
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
St Leonards, Chermside, South Brisbane, Bedford Park
2026-05-06
Not yet open
Benuvia Therapeutics Inc.
Phase 2/3
140
Bedford Park
2026-05-01
Not yet open
HONYA Medical Co Ltd
Phase 2
102
Bedford Park
2026-03-30
Recruiting
Adcendo ApS
Phase 1
180
Randwick, Bedford Park, Clayton, Melbourne
2026-03-17
Recruiting
Nura Bio
Phase 1/2
80
Concord, Randwick, Brisbane, Bedford Park, Caulfield South, Nedlands
2026-03-04
Recruiting
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
NCT07349212Peanut-Induced Anaphylaxis, Peanut Allergy
Ukko Inc
Phase 1/2
40
Camperdown, Bedford Park, Fitzroy, Perth
2026-02-18
Recruiting
Eli Lilly and Company
Phase 3
800
Adelaide, Bedford Park, Box Hill, Brisbane, Heidelberg West, Maroochydore, Southport, Spearwood
2026-02-10
Recruiting
Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
NCT07435038Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Phase 1/2
120
Blacktown, Randwick, Sydney, Bedford Park, Heidelberg, Nedlands
2026-01-29
Recruiting
Boehringer Ingelheim
Phase 3
400
Bedford Park, Subiaco, Heidelberg, Sydney, Woolloongabba
2026-01-16
Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322IDH-mutant Grade 2 or 3 Astrocytoma
DrugVorasidenib
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
468
Bedford Park, Camperdown, Heidelberg, Hobart, Liverpool, Melbourne, Nedlands, St Leonards
2026-01-16
Recruiting
Kahr Bio Australia Pty Ltd
Phase 2
90
Woodville, Camperdown, Port Macquarie, Westmead, South Brisbane, Bedford Park, Clayton, Footscray
2026-01-16
Recruiting
BioNTech SE
Phase 2
105
Bedford Park, Benowa, Frankston, Melbourne, Mount Pleasant, Saint Leonards, Sunshine Coast, Sydney
2025-12-04
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Camperdown, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg, Melbourne
2025-11-12
Recruiting
Flinders University
Phase 2
15
Bedford Park
2025-10-31
Not yet open
Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis
NCT07093268Amyotrophic Lateral Sclerosis, Motor Neuron Disease
DrugRiluzole
Brain Trust Bio
Phase 1
10
Birtinya, Bedford Park
2025-08-15
Recruiting
Amgen
Phase 3
12,800
Charlestown, Darlinghurst, St Leonards, Auchenflower, Herston, Milton, Woolloongabba, Bedford Park
2025-07-25
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Adelaide, Bedford Park, Box Hill, Chermside, Darlinghurst, Joondalup, Liverpool, Westmead
2025-07-02
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Camperdown, Darlinghurst, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg
2025-07-02
Recruiting
Novo Nordisk A/S
Phase 2
200
Concord, Brisbane, Adelaide, Bedford Park, Hobart, Clayton, Murdoch
2025-06-30
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bedford Park, Camperdown, Fitzroy, Kogarah, Melbourne, Woolloongabba
2025-06-04
Recruiting
Eikon Therapeutics
Phase 2/3
740
Wollongong, Chermside, Bedford Park, Box Hill, Frankston
2025-05-22
Active, closed
Alkermes, Inc.
Phase 2
126
Sydney, Bedford Park, Clayton
2025-05-22
Recruiting
Penumbra Inc.
Observational
300
Bedford Park, Sydney
2025-05-18
Recruiting
BioNTech SE
Phase 1/2
594
Camperdown, Bedford Park, Bendigo, Geelong, Saint Albans, Subiaco
2025-05-02
Recruiting
AP Biosciences Inc.
Phase 1/2
85
Macquarie, Bedford Park, Perth
2025-04-22
Recruiting
Nimbus Wadjet, Inc.
Phase 1/2
134
Liverpool, Bedford Park
2025-03-31
Recruiting
Daiichi Sankyo
Phase 3
726
Bedford Park, Clayton, Douglas, North Melbourne, St Leonards, Subiaco, Wollongong
2025-02-27
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Bedford Park, Kingswood, South Brisbane, Sydney
2025-01-29
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugALKS 2680
Alkermes, Inc.
Phase 2/3
786
Sydney, Bedford Park, Clayton
2025-01-27
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Camperdown, Penrith, St Leonards, Woolloongabba, Bedford Park, Hobart, Box Hill, Melbourne
2025-01-15
Recruiting
BioNTech SE
Phase 2/3
1,580
Adelaide, Bedford Park, Cairns, Dubbo, Frankston, Joondalup, Kurralta Park, Melbourne
2025-01-07
Active, closed
Genmab
Phase 3
191
Camperdown, Sydney, Southport, Bedford Park, Perth, Subiaco, Fitzroy, Wendouree
2024-11-25
Recruiting
Adcendo ApS
Phase 1
210
Macquarie Park, Randwick, Bedford Park, Frankston, Malvern, Melbourne, Nedlands
2024-11-25
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
DrugsTORL-1-23·Pegfilgrastim
TORL Biotherapeutics, LLC
Phase 2
230
Clayton, Blacktown, Chermside, Bedford Park, Perth
2024-11-20
Active, closed
Daiichi Sankyo
Phase 3
700
Adelaide, Bedford Park, Box Hill, Concord, Darlinghurst, Douglas, Liverpool, Melbourne
2024-11-19
Recruiting
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection
DrugsDaptomycin·Vancomycin
Todd C. Lee MD MPH FIDSA
Phase 4
300
Blacktown, Concord, Newcastle, Westmead, Herston, Bedford Park, Berwick, Box Hill
2024-11-14
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
NCT06561048Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
DrugsBelinostat·Pralatrexate·Soquelitinib
Corvus Pharmaceuticals, Inc.
Phase 3
150
Darlinghurst, Kogarah, South Brisbane, Adelaide, Bedford Park, Hobart, Box Hill, Heidelberg
2024-10-02
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
40
Camperdown, Clayton, St Leonards, Westmead, Wollongong, Woolloongabba, Bedford Park, Melbourne
2024-09-23
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Lismore, Westmead, Wollstonecraft, Douglas, Hervey Bay, Bedford Park, Woodville, Hobart
2024-09-18
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
102
Albury, Bedford Park, St Albans, Traralgon
2024-08-07
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-07-30
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Bedford Park, Herston, Kurralta Park, Melbourne, Perth, Woolloongabba, QLD
2024-07-18
Recruiting
Amgen
Phase 3
450
Camperdown, Toowoomba, Woolloongabba, Bedford Park, Woodville South, Heidelberg
2024-07-17
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
DrugIvosidenib
Servier Bio-Innovation LLC
Phase 3
136
Camperdown, Fitzroy, Nedlands, Bedford Park, Woolloongabba
2024-07-09
Recruiting
Inimmune Corporation
Phase 1
50
Albury, Bedford Park, Malvern
2024-07-01
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Bedford Park, Box Hill, Camperdown, Richmond
2024-06-07
Active, closed
Exelixis
Phase 2/3
600
Port Macquarie, Adelaide, Bedford Park, Camperdown, Murdoch
2024-06-07
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
NCT06343402Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC, KRAS G12C
DrugsBBO-10203·Pembrolizumab
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
350
Darlinghurst, Bedford Park, Woodville South, Frankston, Melbourne, Nedlands
2024-05-22
Recruiting
Daiichi Sankyo
Phase 3
540
Ballarat, Bedford Park, Camperdown, St Albans, Subiaco, Townsville, Woolloongabba
2024-05-21
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-05-13
Recruiting
W.L.Gore & Associates
Observational
2,000
New Lambton Heights, Southport, Bedford Park, Melbourne, Perth, Sydney
2024-05-07
Active, closed
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
NCT06125951Dementia Moderate, Dementia, Mild, Alzheimer Disease
Actinogen Medical
Phase 2/3
247
Darlinghurst, Erina, Kogarah, Macquarie Park, Newcastle, Birtinya, Chermside, Bedford Park
2024-04-12
Active, closed
Takeda
Phase 2
213
Sydney, South Brisbane, Bedford Park, Woodville, Melbourne, Nedlands, Perth, Murdoch
2024-03-29
Recruiting
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
NCT07699328EGFR-Mutant Non-Small Cell Lung Cancer
Voronoi, Inc
Phase 1/2
315
Bedford Park, Clayton
2024-03-26
Active, closed
Ferronova Pty Ltd
Not applicable
60
Adelaide, Bedford Park, Heidelberg, Melbourne
2024-03-21
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Brisbane, Herston, South Brisbane, Adelaide, Bedford Park, Clayton, Heidelberg, Perth
2024-03-13
Recruiting
Takeda
Phase 2
268
Concord, South Brisbane, Bedford Park, Woodville, Footscray, Murdoch, Perth, Epping
2024-03-05
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Port Macquarie, Westmead, Bedford Park, Clayton, Murdoch
2024-02-20
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Bedford Park, Box Hill, Brisbane, Darlinghurst, Joondalup, Melbourne, Westmead
2024-01-11
Recruiting
Daiichi Sankyo
Phase 3
50
Bedford Park, Melbourne
2024-01-05
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Liverpool, Auchenflower, Bedford Park, Clayton, East Melbourne, Melbourne
2023-12-12
Active, closed
VividWhite Pty Ltd
Not applicable
65
Sydney, Bedford Park, Doncaster East, East Melbourne, Fitzroy, Vermont South
2023-12-12
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
NCT06022029Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Lymphoma, Non-Hodgkin
DrugCemiplimab
OncoNano Medicine, Inc.
Phase 1
168
Darlinghurst, Wollongong, Buderim, Southport, Woolloongabba, Bedford Park, Subiaco
2023-10-13
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Concord, Randwick, Douglas, Woolloongabba, Bedford Park, Hobart, Box Hill, Fitzroy
2023-09-18
Recruiting
Phase 1 Study of AWT020 in Advanced Cancer
NCT06092580Advanced Cancer
DrugAWT020
Anwita Biosciences
Phase 1
60
South Brisbane, Bedford Park, Clayton, Melbourne
2023-09-15
Recruiting
Inipharm Australia Pty Ltd
Phase 1
168
Camperdown, Campbelltown, Newcastle, Saint Leonards, Woolloongabba, Birtinya, Bedford Park, Box Hill
2023-09-08
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 2
40
Woolloongabba, Bedford Park, Parkville
2023-09-07
Recruiting
Reboxetine for Sleep Apnoea After ENT Surgery
NCT05978505Sleep Apnea, Obstructive
DrugReboxetine
Flinders University
Phase 2
20
Bedford Park
2023-08-10
Recruiting
Myeloid Therapeutics
Phase 1
48
Darlinghurst, Randwick, Westmead, Bedford Park, Malvern, Nedlands
2023-08-02
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1/2
67
Blacktown, Macquarie Park, Bedford Park, Melbourne, Nedlands
2023-07-10
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Bedford Park, Box Hill, Midland, Spearwood
2023-06-28
Recruiting
DynamiCure Biotechnology
Phase 1
320
Randwick, Sydney, Buderim, Bedford Park, Woodville South, Clayton, Malvern, Nedlands
2023-06-28
Active, closed
Grey Wolf Therapeutics
Phase 1/2
300
Bedford Park, Blacktown, Darlinghurst, Heidelberg, Melbourne, South Brisbane, Wollongong
2023-05-21
Active, closed
Gilead Sciences
Phase 3
654
Queensland, Darlinghurst, Liverpool, St Leonards, Auchenflower, Bedford Park, Hobart, Melbourne
2023-05-08
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Camperdown, Kingswood, Wollongong, Bedford Park, Darlinghurst, Bendigo, Frankston, Geelong
2023-04-30
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Greenslopes, Melbourne, Murdoch, Bedford Park, Westmead
2023-03-30
Recruiting
Fore Biotherapeutics
Phase 2
254
New Lambton Heights, Orange, Randwick, Bedford Park, Melbourne
2023-02-21
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2
38
Saint Leonards, Sydney, Westmead, Herston, Adelaide, Bedford Park, Ballarat Central, Box Hill
2023-01-23
Active, closed
Klus Pharma Inc.
Phase 2
240
Auchenflower, Bedford Park, Kogarah
2023-01-17
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Blacktown, Lismore, Liverpool, Wollstonecraft, Bedford Park, North Adelaide, Box Hill, Geelong
2023-01-16
Active, closed
Daiichi Sankyo
Phase 3
1,170
Adelaide, Bedford Park, Frankston, Kogarah, Wollongong, Woolloongabba
2023-01-11
Recruiting
AstraZeneca
Phase 3
3,527
Adelaide, Bedford Park, New Lambton Heights, Port Macquarie, South Brisbane
2022-12-13
Recruiting
Stalicla SA
Observational
1,500
South Brisbane, Bedford Park, Melbourne, Parkville
2022-10-13
Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
NCT05519449Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Castration Resistant Prostatic Cancer
DrugsJANX007·Darolutamide
Janux Therapeutics
Phase 1
272
Camperdown, Bedford Park, Nedlands
2022-09-15
Recruiting
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NCT05325034Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis, Hypercholesterolemia
Stephen Nicholls
Not applicable
2,000
Wollongong, Cairns, Bedford Park, Clayton, Melbourne
2022-09-15
Active, closed
Exelixis
Phase 3
901
Albury, Bankstown, Bedford Park, Heidelberg, Melbourne, Port Macquarie, Woodville South
2022-09-07
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bedford Park, Footscray, Kurralta Park, Liverpool, Newcastle, Southport, Sydney, Westmead
2022-08-17
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1/2
442
Sydney, Malvern, Melbourne, Nedlands, Bedford Park
2022-08-03
Active, closed
Celgene
Phase 3
939
Birtinya, Douglas, Adelaide, Bedford Park, Clayton, East Melbourne, Melbourne, Murdoch
2022-06-23
Recruiting
Antengene Therapeutics Limited
Phase 1
98
Sydney, Benowa, Bedford Park, Frankston, Mount Pleasant
2022-06-07
Active, closed
Gilead Sciences
Phase 2
193
Bowral, Darlinghurst, Kogarah, Benowa, Birtinya, Bedford Park, Windsor Gardens, Frankston
2022-05-30
Active, closed
IO Biotech
Phase 3
407
Albury, Westmead, Wollongong, Cairns, Bedford Park, Woodville South, Birtinya, Melbourne
2022-05-17
Active, closed
Bausch Health Americas, Inc.
Phase 3
524
Concord, Kingswood, Bedford Park, Box Hill, Parkville, Murdoch, Perth
2022-04-07
Recruiting
Aulos Bioscience, Inc.
Phase 1/2
159
Miranda, Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Saint Albans
2022-04-04
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Camperdown, Macquarie University, Westmead, Adelaide, Bedford Park, Box Hill, Heidelberg, Subiaco
2022-03-07
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Adelaide, Bedford Park, Campbelltown, Chermside, Clayton, Halls Creek, Heidelberg, Melbourne
2022-02-07
Recruiting
Pfizer
Phase 2
91
Liverpool, Mount Kuring-Gai, Waratah, Bedford Park, Kurralta Park, Melbourne, Perth
2022-02-02
Recruiting
Zimmer Biomet
Observational
167
Sydney, Bedford Park, Melbourne
2022-01-02
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
54
Garran, Albury, Newcastle, Herston, Bedford Park, Fitzroy, Melbourne, Nedlands
2021-12-08
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Bedford Park, Heidelberg, Liverpool, Murdoch
2021-12-02
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Botany, New Lambton Heights, Auchenflower, Milton, Woolloongabba, Adelaide, Bedford Park, Leabrook
2021-11-23
Active, closed
Gilead Sciences
Phase 3
603
Albury, Bowral, Darlinghurst, Birtinya, Greenslopes, Bedford Park, Hobart, Box Hill
2021-11-17
Active, closed
AbbVie
Observational
873
Miranda, Woolloongabba, Bedford Park, East Melbourne, Victoria Park, Newtown
2021-11-17
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Adelaide, Camperdown, Randwick, Westmead, Southport, Bedford Park, Clayton, Fitzroy
2021-11-01
Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
NCT04889872Aortic Stenosis, Calcific, Aortic Valve Stenosis
Edwards Lifesciences
Not applicable
2,250
Chermside, Adelaide, Bedford Park, Clayton
2021-10-12
Recruiting
Penumbra Inc.
Observational
1,500
Westmead, Bedford Park
2021-06-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Bedford Park, Clayton, Garran, Heidelberg, Melbourne, Waratah
2021-06-24
Recruiting
Hoffmann-La Roche
Phase 1/2
316
Bedford Park, Frankston, Melbourne, Nedlands
2021-06-22
Active, closed
Hoffmann-La Roche
Observational
800
Camperdown, Liverpool, St Leonards, Bedford Park, East Melbourne
2021-05-10
By invitation
Cytokinetics
Phase 2/3
900
Bedford Park, Chermside, Murdoch
2021-05-06
Active, closed
Incyte Corporation
Phase 3
654
Kogarah, Sydney, Wollongong, Southport, Adelaide, Bedford Park, Melbourne, St Albans
2021-04-15
Active, closed
IDEAYA Biosciences
Phase 1
169
Darlinghurst, Bedford Park
2021-04-14
Recruiting
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT04634916Kidney Disease, End-Stage, End-stage Renal Disease, Arteriovenous Fistula
C. R. Bard
Not applicable
220
Bedford Park
2021-03-26
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Mackay, Bedford Park, Clayton, Douglas, St Leonards, Tweed Heads, Wollongong, Woolloongabba
2021-02-23
Active, closed
Genmab
Phase 3
483
Bedford Park, Concord, Frankston, South Brisbane, Waratah, Westmead
2021-01-13
Active, closed
BioNTech SE
Phase 2/3
358
Adelaide, Bedford Park, Fitzroy, Saint Leonards, Tugun, Wollongong
2021-01-07
Active, closed
Daiichi Sankyo
Phase 3
605
Bedford Park, Blacktown, Heidelberg, North Ryde, Sydney, Wollongong
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bedford Park, Box Hill, Sydney
2020-12-18
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Bedford Park
2020-12-07
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ballarat, Bedford Park, Clayton, Garran, Hyde Park, Port Macquarie, Wollongong, Woolloongabba
2020-12-02
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Kogarah, Bedford Park, Geelong, Melbourne
2020-11-25
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor
DrugsRezatapopt·Keytruda·Pembrolizumab
PMV Pharmaceuticals, Inc
Phase 1/2
300
Camperdown, South Brisbane, Bedford Park, Clayton, Nedlands
2020-10-29
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bedford Park, Heidelberg, Malvern, Murdoch, Nedlands, Westmead, Wollongong, Woolloongabba
2020-09-30
Recruiting
ImmVira Pharma Co. Ltd
Phase 1/2
30
Bedford Park, Frankston, Melbourne
2020-09-17
Active, closed
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
NCT04140526Non Small Cell Lung Cancer, Advanced Solid Tumor, Metastatic Melanoma, Metastatic Head and Neck Carcinoma
DrugsGotistobart·Taxotere·Docetaxel·Keytruda
OncoC4, Inc.
Phase 1/2
733
New Lambton Heights, Southport, Adelaide, Bedford Park
2020-09-16
Recruiting
Takeda
Phase 2
160
Albury, Tweed Heads, Westmead, Douglas, Adelaide, Bedford Park, Box Hill, Geelong
2020-08-19
Active, closed
Actelion
Phase 3
935
Bedford Park, Camperdown, Chermside, Darlinghurst, Hobart, Murdoch, Westmead
2020-06-30
Active, closed
Epizyme, Inc.
Phase 3
599
Adelaide, Bedford Park, Clayton, Geelong, Nedlands, Frankston, Hobart, Southport
2020-06-11
Active, closed
Takeda
Phase 3
354
St Leonards, Woolloongabba, Bedford Park
2020-01-10
Recruiting
Global Coalition for Adaptive Research
Phase 2/3
2,250
St Leonards, Waratah, Herston, Bedford Park, Heidelberg, Melbourne
2019-07-30
Active, closed
Sanofi
Observational
955
Kogarah, Woolloongabba, Bedford Park, Carlton
2019-06-11
Active, closed
AbbVie
Phase 3
964
Garran, Herston, Maroochydore, Southport, Bedford Park, Camberwell, Clayton
2019-03-25
Active, closed
Exelixis
Phase 3
187
St Leonards, Waratah, Bedford Park, Melbourne, Herston
2018-10-05
Active, closed
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
NCT03611868Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma, P53 Mutation
DrugPembrolizumab
Ascentage Pharma Group Inc.
Phase 1/2
230
Brisbane, South Brisbane, Bedford Park, Heidelberg
2018-08-29
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
South Brisbane, Bedford Park, Frankston, Melbourne, Perth
2018-05-03
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
North Sydney, Waratah, Greenslopes, Southport, Bedford Park, Murdoch
2018-04-11
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Randwick, Westmead, Brisbane, Adelaide, Bedford Park, Parkville, Perth
2017-08-10
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Camperdown, Adelaide, Bedford Park
2017-06-26
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Kogarah, Sydney, Woolloongabba, Bedford Park, Ballarat, Box Hill, Clayton, Fitzroy
2017-05-22
Active, closed
Acerta Pharma BV
Phase 3
635
Bedford Park, Concord, Frankston, Gosford, Heidelberg, Herston, Kogarah, Murdoch
2017-04-05
Active, closed
AbbVie
Phase 2
120
East Albury, Waratah, Bedford Park, Hobart
2017-01-19
Recruiting
University of Sydney
Phase 4
50,000
Adelaide, Auburn, Bedford Park, Bentleigh East, Birtinya, Brisbane, Bundaberg, Caloundra
2016-06
Active, closed
Edwards Lifesciences
Not applicable
1,000
Adelaide, Bedford Park
2016-03
Active, closed
Hoffmann-La Roche
Phase 2
534
Liverpool, Newcastle, Bedford Park, Heidelberg
2015-11-19
Active, closed
AstraZeneca
Phase 3
682
Bedford Park, Camperdown, Darlinghurst, Heidelberg, Kogarah, Kurralta Park, Woolloongabba
2015-10-21
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Darlinghurst, Herston, Wooloongabba, Bedford Park, Box Hill, Clayton, Franston, Perth
2015-03-05
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
St Leonards, Sydney, Brisbane, Parkville, Bedford Park, Heidelberg, Hobart, Melbourne
2007-12
Rows per page Showing 1–156 of 156
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/bedford-park

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 156 of those studies with a site in Bedford Park.

How many clinical trials are recruiting in Bedford Park?

80 of the 156 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 5 have not yet opened recruitment, 69 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bedford Park), 156 studies
PhaseStudiesRecruitingShare
Phase 3612439.1%
Phase 2291418.6%
Phase 1/2191312.2%
Phase 115129.6%
Phase 2/31257.7%
Not applicable855.1%
Observational855.1%
Phase 4422.6%

Most active sponsors

Lead sponsors with the most studies (Bedford Park)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche72
Daiichi Sankyo63
Takeda64
Janssen Research & Development, LLC51
BioNTech SE43
Gilead Sciences41
AbbVie30
Amgen32
Australasian Gastro-Intestinal Trials Group32
EMD Serono Research & Development Institute, Inc.31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.